Literature DB >> 33563579

Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell Leukemia.

Ricardo D Parrondo1, Muhamad Alhaj Moustafa1, Craig Reeder2, Taimur Sher1, Vivek Roy1, Eli Muchtar3, Rahma Warsame3, Victoria Alegria1, Wilson Gonsalves3, David Dingli3, Suzanne Hayman3, Prashant Kapoor3, Asher A Chanan-Khan1, Sikander Ailawadhi4.   

Abstract

Entities:  

Keywords:  Immunotherapy; Monoclonal antibodies; Multiple myeloma; Plasma cell dyscrasias; Targeted therapy

Mesh:

Substances:

Year:  2021        PMID: 33563579     DOI: 10.1016/j.clml.2021.01.002

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN: 2152-2669


× No keyword cloud information.
  1 in total

1.  Case report: Plasma cell leukemia secondary to multiple myeloma successfully treated with anti-BCMA CAR-T cell therapy.

Authors:  Jingjing Deng; Yuehui Lin; Defeng Zhao; Chunrong Tong; Alex H Chang; Wenming Chen; Wen Gao
Journal:  Front Oncol       Date:  2022-09-21       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.